Timothy Vollmer

Overview

Best Publications

• B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

  Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer

  2801
  Citations

• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis Results of a phase III multicenter, double‐blind, placebo‐controlled trial

  K. P. Johnson;B. R. Brooks;J. A. Cohen;C. C. Ford

  2459
  Citations

• THE FUNCTIONS OF SELF‐INJURIOUS BEHAVIOR: AN EXPERIMENTAL‐EPIDEMIOLOGICAL ANALYSIS

  Brian A. Iwata;Gary M. Pace;Michael F. Dorsey;Jennifer R. Zarcone

  1168
  Citations

• Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

  Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  1067
  Citations

• Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

  Peter A. Calabresi;Ernst Wilhelm Radue;Douglas Goodin;Douglas Jeffery

  930
  Citations

• Proposed diagnostic criteria and nosology of acute transverse myelitis

  G. Barnes;S. Benjamin;J. D. Bowen;N. Cutter

  814
  Citations

• Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

  Kenneth P. Johnson;B. R. Brooks;Jeffrey A Cohen;C. C. Ford

  714
  Citations

• Prevalence and treatment of spasticity reported by multiple sclerosis patients

  M A Rizzo;O C Hadjimichael;J Preiningerova;T L Vollmer

  655
  Citations

• Oral simvastatin treatment in relapsing-remitting multiple sclerosis.

  Timothy Vollmer;Lyndon Key;Valerie Durkalski;William Tyor;William Tyor

  619
  Citations

• Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with parkinson’s disease

  Dennis D. Spencer;Dennis D. Spencer;Richard J. Robbins;Frederick Naftolin;Frederick Naftolin;Kenneth L. Marek;Kenneth L. Marek

  611
  Citations

• Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

  Ruth Ann M Marrie;R. Rudick;R. Horwitz;G. Cutter

  521
  Citations

• Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

  Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle

  514
  Citations

• Brain health: time matters in multiple sclerosis

  Gavin Giovannoni;Helmut Butzkueven;Suhayl Dhib-Jalbut;Jeremy Hobart

  495
  Citations

• Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

  Daniel Wynn;Michael Kaufman;Xavier Montalban;Timothy Vollmer

  421
  Citations

• Employment in multiple sclerosis. Exiting and re-entering the work force.

  Laura J. Julian;Lea Vella;Tim Vollmer;Olympia Hadjimichael

  368
  Citations

• Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

  K. P. Johnson;B. R. Brooks;C. C. Ford;A. Goodman

  339
  Citations

• Reliability and validity of two self-report measures of impairment and disability for MS

  C. E. Schwartz;T. Vollmer;Hang Lee

  331
  Citations

• Treatment of Self-Injury and Hand Mouthing Following Inconclusive Functional Analyses.

  Timothy R. Vollmer;Bethany A. Marcus;Linda LeBlanc

  330
  Citations

• Persistent pain and uncomfortable sensations in persons with multiple sclerosis.

  Olympia Hadjimichael;Robert D. Kerns;Marco A. Rizzo;Gary Cutter

  323
  Citations

• Comorbidity delays diagnosis and increases disability at diagnosis in MS

  R. A. Marrie;R. Horwitz;G. Cutter;T. Tyry

  314
  Citations